Hey ddzx,
They have to get it to the lab first, get the results back, AND undetake analysis, AND put them through the board. its not an immediate process.
My point being....unless Mgt extend the SPP, the underwriter, and not their shareholders, is going to have the benefit/choice of seeing the results. This is ethically wrong in any U/W.
sulphides intercepted at second target, page-54
Add MEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $42.37M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.8¢ | $6.848K | 173.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 134634 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 194999 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| MEU (ASX) Chart |